Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

It’s easy to view cognitive decline as an inevitable slide that we are powerless to fight. But knowing the early signs - ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

BEIJING -- China has rolled out a national action plan to address senile dementia, which poses significant challenges to the ...

A WORD on the tip of the tongue or a forgotten birthday – everyone has occasional memory blanks. While forgetting things ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

China aims to establish a comprehensive system to significantly curb the overall growth in the incidence rate of ...

Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues ...